Categories
Archives
- 2026
- 2025
- 2024
- 2023
- 2022
- 2021
Jun
13
Tu Salud Tu Familia Generates Awareness for Rare Diseases such as Myasthenia Gravis
Jun
12
UCB Announces Major U.S. Investment to Expand Biologics Manufacturing Capacity
Jun
11
BIMZELX® (bimekizumab-bkzx) Three-Year Data at EULAR 2025 Showed Lasting Efficacy and Control of Inflammation in Psoriatic Arthritis and Axial Spondyloarthritis
Jun
04
Resources for Resilience: Dravet Syndrome Awareness Month for Families Living with DEEs
Jun
02
Partnering with Patient Communities to Advance HS Awareness and Care
May
30
Recognizing Myasthenia Gravis Month – The Importance of Addressing Unmet Patient Needs
Apr
22
Earth Day 2025: Advancing Our Commitment to a Healthier Planet
Apr
03
UCB presents latest research across leading neurology portfolio at American Academy of Neurology (AAN) meeting 2025
Mar
31
The First UCB US Rare Disease Connect in Neurology (RDCN) Annual Summit Launches at American Academy of Neurology 2025
